Example: Heart Attack

Clinical Trials on Glaucoma, Neovascular

Total 28 results

NCT04844619

Not yet recruiting

KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial

Conditions: Neovascular Glaucoma, Neovascularization
NCT02805257

Completed

Ahmed Glaucoma Valve Surgery With Mitomycin-C

Conditions: Glaucoma, Primary Open Angle Glaucoma, Secondary Glaucoma, Neovascular Glaucoma
NCT04519619

Recruiting

Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

Conditions: Neovascular Glaucoma
NCT01711879

Completed

Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma

Conditions: Neovascular Glaucoma
NCT03187418

Completed

Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma

Conditions: Glaucoma, Glaucoma, Open-Angle, Glaucoma, Neovascular, Glaucoma and Ocular Hypertension, Glaucoma Eye, Glaucoma, Uncompensated, Glaucoma Secondary
NCT04381611

Recruiting

INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register

Conditions: Glaucoma Open-Angle, Glaucoma Eye, Glaucoma; Drugs, Glaucoma, Angle-Closure, Glaucoma Secondary, Glaucoma, Neovascular, Glaucoma Congenital, Surgery, Glaucoma, Pigmentary, Glaucoma Capsulare
NCT03648814

Recruiting

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

Conditions: Glaucoma, Neovascular, Vascular Endothelial Growth Factor Overexpression
NCT03639675

Completed

Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied

Conditions: Glaucoma, Neovascular
NCT00727038

Withdrawn

Lucentis for New Onset Neovascular Glaucoma

Conditions: Glaucoma, New Onset Glaucoma, Neovascular Glaucoma, New Onset Neovascular Glaucoma
NCT04215575

Completed

Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases

Conditions: Glaucoma, Open-Angle, Glaucoma Secondary, Glaucoma, Neovascular, Glaucoma, Angle-Closure
NCT04214847

Completed

The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases

Conditions: Glaucoma, Open-Angle, Glaucoma Secondary, Glaucoma, Neovascular
NCT01908816

Completed

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Conditions: Choroidal Neovascularization, Macular Edema, Glaucoma, Neovascular, Diabetic Retinopathy
NCT03154892

Completed

The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma

Conditions: Neovascular Glaucoma
NCT02396316

Completed

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

Conditions: Glaucoma, Neovascular
NCT00524758

Completed

Oculusgen (Ologen) Glaucoma MMC Control in Estonia

Conditions: Open Angle Glaucoma, Angle Closure Glaucoma, Uveitis Glaucoma, Young Age Glaucoma, Neovascular Glaucoma, High Risk Patient
NCT02067013

Unknown status

Analysis of Aqueous and Vitreous Humor

Conditions: Proliferative Diabetic Retinopathy, Macular Degeneration, Macular Hole, Neovascular Glaucoma
NCT01301378

Terminated

Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube

Conditions: Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma, Pseudoexfoliation Glaucoma, Pigmentary Glaucoma, Traumatic Glaucoma, Uveitic Glaucoma, Neovascular Glaucoma
NCT02947867

Unknown status

Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG

Conditions: Ischaemic Central Retinal Vein Occlusion, Neovascular Glaucoma
NCT02914626

Unknown status

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

Conditions: Glaucoma, Neovascular, Ranibizumab
NCT02647515

Completed

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

Conditions: Diabetic Retinopathy, Glaucoma, Neovascular
NCT01983579

Terminated

TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection

Conditions: Neovascular Age Related Macular Degeneration (AMD), Open Angle Glaucoma
NCT02260219

Unknown status

Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma

Conditions: Neovascular Glaucoma
NCT01922154

Completed

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Conditions: Glaucoma, Neovascular
NCT01370135

Completed

Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma

Conditions: Neovascular Glaucoma, Rubeosis
NCT00441181

Withdrawn

Effects of Travoprost on Neovascular Glaucoma

Conditions: Neovascular Glaucoma